Yadav Neelam, Kumar Ravi, Sangwan Sarita, Dhanda Vidhi, Duhan Anil, Sindhu Jayant
Department of Chemistry, Chaudhary Charan Singh Haryana Agricultural University Hisar, Hisar, Haryana, India.
MAP Section, Department of Genetics and Plant Breeding, Chaudhary Charan Singh Haryana Agricultural University Hisar, Hisar, Haryana, India.
Future Med Chem. 2024 Dec;16(24):2637-2646. doi: 10.1080/17568919.2024.2432289. Epub 2024 Nov 28.
Oxidative stress, caused by postprandial activities, is a major global health issue causing chronic diseases like diabetes mellitus, cancer, and asthma. Therefore, it was envisaged to design and synthesize a series of substituted 4-hydroxypyridine-2(1 h)-ones in order to develop new molecules that can reduce oxidative stress and modulate α-amylase activity also.
MATERIALS & METHODS: An environmentally benign, solvent and catalyst free, natural product inspired synthesis of 4-hydroxypyridin-2(1 h)-one derivatives has been developed. The synthetic analogues were evaluated in vitro α-amylase activity and antioxidant potential.
Among all the synthesized compounds, , and displayed many folds higher antioxidants activity than the standard, BHT. The in vitro α-amylase inhibition was found to be moderate with IC values ranging from 5.48 to 9.31 mm as compared to the standard acarbose (IC = 0.65 mm). The most active compound against α-amylase 4c was further investigated for its binding affinity within the active site of the enzyme and the kinetics studies revealed probable uncompetitive mode of inhibition.
Compound 4a was found to be promising antioxidant and 4c as a good α-amylase inhibitor. These compounds could pave the way for development of new α-amylase inhibitors with antioxidant capabilities thereby effectively mitigating diabetes mellitus.
餐后活动引起的氧化应激是一个重大的全球健康问题,会引发糖尿病、癌症和哮喘等慢性疾病。因此,设想设计并合成一系列取代的4-羟基吡啶-2(1H)-酮,以开发能够降低氧化应激并调节α-淀粉酶活性的新分子。
开发了一种受天然产物启发的、环境友好、无溶剂和无催化剂的4-羟基吡啶-2(1H)-酮衍生物合成方法。对合成类似物进行了体外α-淀粉酶活性和抗氧化潜力评估。
在所有合成化合物中,[此处原文可能缺失具体化合物信息]显示出比标准品丁基羟基甲苯(BHT)高许多倍的抗氧化活性。与标准阿卡波糖(IC50 = 0.65 mM)相比,体外α-淀粉酶抑制作用中等,IC50值范围为5.48至9.31 mM。对α-淀粉酶活性最高的化合物4c进一步研究其在酶活性位点内的结合亲和力,动力学研究揭示了可能的非竞争性抑制模式。
发现化合物4a是有前景的抗氧化剂,4c是良好的α-淀粉酶抑制剂。这些化合物可为开发具有抗氧化能力的新型α-淀粉酶抑制剂铺平道路,从而有效缓解糖尿病。